Cytek Biosciences, Inc. (CTKB) vs VAREX IMAGING (VREX)
Cytek Biosciences, Inc. and VAREX IMAGING are both Medical Devices companies. Cytek Biosciences, Inc. and VAREX IMAGING are of similar size ($784.3M and $744.8M). Cytek Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; VAREX IMAGING trades at 34.8×. Cytek Biosciences, Inc. grew revenue faster over the last twelve months: 5.44% against 5.31%. VAREX IMAGING has the higher net margin (2.55% vs −39.0%) and the higher return on invested capital (5.95% vs −46.4%). Across the 18 metrics below, VAREX IMAGING leads on 12 and Cytek Biosciences, Inc. on 6.
Valuation
Profitability
| Metric | CTKB | VREX | Medical Devices median |
|---|---|---|---|
| Gross margin | 53.23% | 34.32% | 56.01% |
| Operating margin | (21.60%) | 8.35% | (15.03%) |
| Net margin | (38.98%) | 2.55% | (20.40%) |
| Free cash flow margin | (5.79%) | (2.34%) | (7.24%) |
| Return on equity | (23.04%) | 4.51% | (15.32%) |
| Return on assets | (17.14%) | 2.03% | (19.72%) |
| Return on invested capital | (46.36%) | 5.95% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack